You are here

Article info

Article menu
Download PDFPDF
Correspondence
Is it time to redefine the role of low-dose radiotherapy for benign disease?

Authors

  1. Correspondence to Dr Meritxell Arenas, Department of Radiation Oncology, Hospital Universitari Sant Joan de Reus, University of Rovira i Virgili, Tarragona, Spain; meritxell.arenas{at}gmail.com
View Full Text

Citation

Montero A, Sabater S, Rödel F, et al
Is it time to redefine the role of low-dose radiotherapy for benign disease?
Annals of the Rheumatic Diseases 2020;79:e34.

Publication history

  • Received December 4, 2018
  • Accepted December 8, 2018
  • First published December 21, 2018.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.